Árpád Szomor

Variations in clinical presentation, frequency of hemophagocytosis and clinical behavior of intravascular lymphoma diagnosed in different geographical regions

Andrés JM Ferreri, Giuseppina Dognini, Elı́as Campo et al. · Haematologica · 2007 · 184 citations · Full text

Medicine, Hematology, Oncology +13

Copanlisib plus rituximab versus placebo plus rituximab in patients with relapsed indolent non-Hodgkin lymphoma (CHRONOS-3): a double-blind, randomised, placebo-controlled, phase 3 trial

Matthew J. Matasar, Marcelo Capra, Muhıt Özcan et al. · The Lancet Oncology · 2021 · 137 citations · Full text

Medicine, Immunology, Pharmacology +11

The addition of rituximab to anthracycline‐based chemotherapy significantly improves outcome in ‘Western’ patients with intravascular large B‐cell lymphoma

Andrés J.M. Ferreri, Giuseppina Dognini, Osnat Bairey et al. · British Journal of Haematology · 2008 · 113 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study

Mohamad Mohty, Evangelos Terpos, María‐Victoria Mateos et al. · Clinical Lymphoma Myeloma & Leukemia · 2018 · 89 citations · Full text

Medicine, Hematology, Pharmacoeconomics +14

Myeloid leukemia and myelodysplastic syndrome relapsing as granulocytic sarcoma (chloroma) after allogeneic bone marrow transplantation

Árpád Szomor, Jakob Passweg, André Tichelli et al. · Annals of Hematology · 1997 · 54 citations

Medicine, Hematology, Oncology +17